AKT1 and prostate carcinoma: Our previous study showed that simvastatin, a lipophilic statin inhibited multiple prostate cancer cell functions in vitro such as migration, proliferation, cell survival and colony formation as well as tumor growth in a nude mouse xenograft in vivo, mainly via inhibition of Akt pathway [5].